Quest Diagnostics (DGX) Leases: 2009-2025
Historic Leases for Quest Diagnostics (DGX) over the last 7 years, with Sep 2025 value amounting to $649.0 million.
- Quest Diagnostics' Leases fell 1.82% to $649.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $649.0 million, marking a year-over-year decrease of 1.82%. This contributed to the annual value of $651.0 million for FY2024, which is 8.14% up from last year.
- Quest Diagnostics' Leases amounted to $649.0 million in Q3 2025, which was down 0.92% from $655.0 million recorded in Q2 2025.
- Quest Diagnostics' 5-year Leases high stood at $661.0 million for Q3 2024, and its period low was $579.0 million during Q1 2024.
- Over the past 3 years, Quest Diagnostics' median Leases value was $611.0 million (recorded in 2023), while the average stood at $623.9 million.
- In the last 5 years, Quest Diagnostics' Leases increased by 17.19% in 2021 and then dropped by 5.00% in 2023.
- Quarterly analysis of 5 years shows Quest Diagnostics' Leases stood at $597.0 million in 2021, then declined by 2.01% to $585.0 million in 2022, then rose by 2.91% to $602.0 million in 2023, then grew by 8.14% to $651.0 million in 2024, then declined by 1.82% to $649.0 million in 2025.
- Its Leases was $649.0 million in Q3 2025, compared to $655.0 million in Q2 2025 and $656.0 million in Q1 2025.